LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 14 of 15: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20251)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Mean Relative Cell Count | Standard Error of the Mean for Relative Cell Count | Mean Normalized Growth Rate Inhibition Value | Standard Error of the Mean for Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|
BT-20 | Y39983 | 1.11 | uM | LJP6 | 0.9132 | 0.0355 | 0.8954 | 0.0421 |
BT-20 | Y39983 | 3.33 | uM | LJP6 | 0.8395 | 0.0444 | 0.8023 | 0.0521 |
BT-20 | Y39983 | 10 | uM | LJP6 | 0.4872 | 0.0719 | 0.2956 | 0.0960 |
BT-20 | Nintedanib | 0.04 | uM | LJP6 | 1.0218 | 0.0279 | 1.0265 | 0.0326 |
BT-20 | Nintedanib | 0.12 | uM | LJP6 | 1.0058 | 0.0431 | 1.0075 | 0.0508 |
BT-20 | Nintedanib | 0.37 | uM | LJP6 | 0.8849 | 0.0643 | 0.8570 | 0.0779 |
BT-20 | Nintedanib | 1.11 | uM | LJP6 | 0.8717 | 0.0442 | 0.8429 | 0.0517 |
BT-20 | Nintedanib | 3.33 | uM | LJP6 | 0.7585 | 0.0330 | 0.6923 | 0.0455 |
BT-20 | Nintedanib | 10 | uM | LJP6 | 0.6248 | 0.0562 | 0.5076 | 0.0683 |
BT-20 | Foretinib | 0.04 | uM | LJP5 | 1.0209 | 0.0231 | 1.0216 | 0.0264 |
BT-20 | Foretinib | 0.12 | uM | LJP5 | 0.8399 | 0.0623 | 0.7989 | 0.0863 |
BT-20 | Foretinib | 0.37 | uM | LJP5 | 0.4442 | 0.0667 | 0.2365 | 0.1248 |
BT-20 | Foretinib | 1.11 | uM | LJP5 | 0.3008 | 0.0228 | -0.0096 | 0.0711 |
BT-20 | Foretinib | 3.33 | uM | LJP5 | 0.2958 | 0.0236 | -0.0192 | 0.0709 |
BT-20 | Foretinib | 10 | uM | LJP5 | 0.2435 | 0.0208 | -0.1243 | 0.0696 |
BT-20 | AZD 5438 | 0.04 | uM | LJP6 | 0.9045 | 0.0422 | 0.8840 | 0.0494 |
BT-20 | AZD 5438 | 0.12 | uM | LJP6 | 0.7288 | 0.0675 | 0.6548 | 0.0828 |
BT-20 | AZD 5438 | 0.37 | uM | LJP6 | 0.5248 | 0.0869 | 0.3540 | 0.1178 |
BT-20 | AZD 5438 | 1.11 | uM | LJP6 | 0.3535 | 0.0478 | 0.0675 | 0.0645 |
BT-20 | AZD 5438 | 3.33 | uM | LJP6 | 0.2582 | 0.0289 | -0.1169 | 0.0583 |
BT-20 | AZD 5438 | 10 | uM | LJP6 | 0.1470 | 0.0249 | -0.3719 | 0.0849 |
BT-20 | Pelitinib | 0.04 | uM | LJP5 | 0.9703 | 0.0335 | 0.9658 | 0.0379 |
BT-20 | Pelitinib | 0.12 | uM | LJP5 | 0.8960 | 0.0497 | 0.8768 | 0.0573 |
BT-20 | Pelitinib | 0.37 | uM | LJP5 | 0.8088 | 0.0059 | 0.7676 | 0.0035 |
BT-20 | Pelitinib | 1.11 | uM | LJP5 | 0.7545 | 0.0187 | 0.6970 | 0.0213 |